Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This research study is being done to see if combining the investigational chemotherapy drug,
MEDI-551 with the known anti-myeloma drugs, Lenalidomide and Dexamethasone will reduce your
myeloma cancer stem cells.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins